Eur Rev Med Pharmacol Sci 2021; 25 (6): 2542-2547

DOI: 10.26355/eurrev_202103_25417

Long-term survival case of a non-small cell lung cancer bone metastasis patient treated with bone cement, radiation and gefitinib

W.-T. Hou, X.-Q. Xie, Y. Luo, C. Yi, F. Luo, J.-B. Kang, F. Wang, Y. Lu, Y.-L. Gong, D.-B. Wu, B.-L. Qu

Department of Medical Oncology, Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China. wangfeng5024@126.com


OBJECTIVE: We explore the treatment of bone metastases in advanced non-small cell lung cancer (NSCLC).

MATERIALS AND METHODS: We reported a 76-year-old female patient, who was diagnosed with NSCLC with bone metastasis eight years ago (stage IVA). Due to unbearable diarrhea, she refused chemotherapy, and we adopted local treatment, including local radiotherapy 50 Gy and bone cement to lumbar spinal metastases, 62 Gy local radiotherapy of primary lung tumor, TKI inhibitor gefitinib and zoledronic acid.

RESULTS: She survived more than eight years and is still in follow-up.

CONCLUSIONS: The median survival time for NSCLC patients with bone metastases is often less than 1 year. We reported the patient with more than eight years of survival, showed that some special cases can adopt the methods of local treatment including bone cement, treatment benefit patients, radiation therapy and targeted therapy in clinic to expand the survival.

Free PDF Download

To cite this article

W.-T. Hou, X.-Q. Xie, Y. Luo, C. Yi, F. Luo, J.-B. Kang, F. Wang, Y. Lu, Y.-L. Gong, D.-B. Wu, B.-L. Qu
Long-term survival case of a non-small cell lung cancer bone metastasis patient treated with bone cement, radiation and gefitinib

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 6
Pages: 2542-2547
DOI: 10.26355/eurrev_202103_25417